Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 5/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 5/20 | 0.42 |
| ▸ | AURKA | O14965 | 1/20 | 0.42 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | CDK1 | P06493 | 2/20 | 0.38 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.38 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.38 |
| ▸ | CDK2 | P24941 | 1/20 | 0.38 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19281406 | 0.75 | CYP1A2 (0.46) | XDHCYP1A2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL17580836 | 0.72 | NAAA (0.54) | KDM4EHTTNAAAEPHX1 | |
| SCHEMBL30545066 | 0.71 | EPHX1 (0.57) | KDM4ENAAAEPHX1 | |
| SCHEMBL3298684 | 0.70 | BRD4 (0.56) | CYP1A2CYP3A4HDAC1HDAC2AURKA | |
| SCHEMBL24846612 | 0.69 | CYP1A2 (0.62) | XDHCYP1A2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL13263618 | 0.69 | NAAA (0.49) | KDM4EHTTNAAAEPHX1 | |
| SCHEMBL16146152 | 0.69 | CYP3A4 (0.61) | XDHCYP1A2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL10780680 | 0.68 | NAAA (0.51) | KDM4ENAAAEPHX1 | |
| SCHEMBL2352832 | 0.68 | TSHR (0.55) | KDM4EHTTNAAAEPHX1 | |
| SCHEMBL28878261 | 0.67 | XDH (0.47) | XDHCYP1A2CYP3A4CYP2D6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250108007-A1 | LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION | Suzhou Abogen Biosciences Co., Ltd. (CN) | 2025-04-03 | — | — | US | disclosed |
| WO-2024199282-A1 | LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION | 苏州艾博生物科技有限公司 | 2024-10-03 | — | — | WO | disclosed |
| EP-4424670-A1 | LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION | Suzhou Abogen Biosciences Co., Ltd. (CN) | 2024-09-04 | — | — | EP | disclosed |
| WO-2024109798-A1 | LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION | 苏州艾博生物科技有限公司 | 2024-05-30 | — | — | WO | disclosed |
| WO-2024083172-A1 | LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION | 苏州艾博生物科技有限公司 | 2024-04-25 | — | — | WO | disclosed |
| WO-2024083171-A1 | LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION | 苏州艾博生物科技有限公司 | 2024-04-25 | — | — | WO | disclosed |
| WO-2024022263-A1 | LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION | 苏州艾博生物科技有限公司 | 2024-02-01 | — | — | WO | disclosed |
| WO-2023116804-A1 | LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION | 苏州艾博生物科技有限公司 | 2023-06-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250108007-A1 | LIPID COMPOUND AND LIPID NANOPARTICLE COMPOSITION | CETP, NPC1, LCAT | XDH 3817/4885CYP1A2 2501/4885CYP3A4 3088/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.